A staff member works at a warehouse of a pharmaceutical company in Xi'an, northwest China's Shaanxi Province, Dec. 19, 2022. Many pharmaceutical companies in China are working at full capacity to increase the medicine supply as the country continues to optimize COVID-19 epidemic prevention and control measures. [Photo by Zou Jingyi/Xinhua] |
A staff member works at a packaging workshop of a pharmaceutical company in Xi'an, northwest China's Shaanxi Province, Dec. 19, 2022. Many pharmaceutical companies in China are working at full capacity to increase the medicine supply as the country continues to optimize COVID-19 epidemic prevention and control measures. [Photo by Zou Jingyi/Xinhua] |
Staff members work at a packaging workshop of a pharmaceutical company in Xi'an, northwest China's Shaanxi Province, Dec. 19, 2022. Many pharmaceutical companies in China are working at full capacity to increase the medicine supply as the country continues to optimize COVID-19 epidemic prevention and control measures. [Photo by Zou Jingyi/Xinhua] |
Staff members pack medicines at a pharmaceutical company in central China's Hunan Province, Dec. 19, 2022. Many pharmaceutical companies in China are working at full capacity to increase the medicine supply as the country continues to optimize COVID-19 epidemic prevention and control measures. [Xinhua/Chen Sihan] |
Staff members pack medicines at a pharmaceutical company in central China's Hunan Province, Dec. 19, 2022. Many pharmaceutical companies in China are working at full capacity to increase the medicine supply as the country continues to optimize COVID-19 epidemic prevention and control measures. [Xinhua/Chen Sihan] |
Staff members pack medicines at a pharmaceutical company in central China's Hunan Province, Dec. 19, 2022. Many pharmaceutical companies in China are working at full capacity to increase the medicine supply as the country continues to optimize COVID-19 epidemic prevention and control measures. [Xinhua/Chen Sihan] |
(Source: Xinhua)
32.3KPlease understand that womenofchina.cn,a non-profit, information-communication website, cannot reach every writer before using articles and images. For copyright issues, please contact us by emailing: [email protected]. The articles published and opinions expressed on this website represent the opinions of writers and are not necessarily shared by womenofchina.cn.
California's population grew in 2023, halting 3 years of decline
U.S. quietly signs off more bombs, fighter jets for Israel: U.S. media
HKSAR chief executive signs safeguarding national security ordinance
Putin says Moscow terror attack committed by radical Islamists, more questions remain
Facebook and Instagram face European Union scrutiny over possible breaches of digital rulebook
Operator of Japan's wrecked Fukushima Daiichi nuclear plant prepares to restart another plant
Hong Kong Customs busts largest gold
Asian economy forecast to grow 4.5 pct in 2024: report
Lilly rides Mounjaro, Zepbound to better
Gang violence takes toll on Haiti health facilities: UN